| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
interferon alpha 1 | 0.371 | 0.923 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 2014 | 2019 | |||||||||
|
interferon alpha 13 | 0.374 | 0.923 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 2014 | 2019 | |||||||||
|
cytochrome c oxidase subunit II | 0.352 | 0.962 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2001 | 2019 | |||||||||
|
microRNA 155 | 0.384 | 0.885 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2015 | 2019 | |||||||||
|
MT-CO2 pseudogene 12 | 0.368 | 0.962 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2001 | 2017 | |||||||||
|
interferon beta 1 | 0.421 | 0.846 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2009 | 2018 | |||||||||
|
microRNA 21 | 0.363 | 0.846 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2018 | 2019 | |||||||||
|
T cell receptor beta variable 20/OR9-2 (non-functional) | 0.403 | 0.923 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1994 | 2019 | |||||||||
|
long intergenic non-protein coding RNA 2605 | 0.490 | 0.769 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2009 | 2019 | |||||||||
|
H3 histone pseudogene 10 | 0.350 | 0.846 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2018 | |||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2019 | |||||||||
|
immunoglobulin heavy constant gamma 3 (G3m marker) | 0.513 | 0.769 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2019 | |||||||||
|
microRNA 23b | 0.523 | 0.808 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2019 | |||||||||
|
microRNA 30b | 0.555 | 0.808 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2011 | 2012 | |||||||||
|
CXADR pseudogene 1 | 0.463 | 0.846 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2014 | 2017 | |||||||||
|
HOXA transcript antisense RNA, myeloid-specific 1 | 0.638 | 0.538 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
Photoparoxysmal response 1 | 0.729 | 0.423 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
endogenous retrovirus group K member 20 | 0.533 | 0.692 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
Cholangitis, primary sclerosing | 0.603 | 0.731 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
immunoglobulin heavy variable 4-38-2-like | 0.514 | 0.769 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8 | 0.527 | 0.769 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
proline and glutamate rich with coiled coil 1 | 0.552 | 0.808 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2020 | 2020 | |||||||||
|
Pulmonary disease, chronic obstructive, severe early-onset | 0.456 | 0.885 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
Hypercalciuria, absorptive, 1 | 0.633 | 0.654 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
immunoglobulin heavy variable 3/OR16-7 (pseudogene) | 0.566 | 0.654 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 |